Virginia Retirement Systems’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,928
Closed -$914K 1108
2025
Q1
$914K Buy
+6,928
New +$863K 0.01% 578
2023
Q3
$208K Buy
+4,000
New +$233K ﹤0.01% 875
2023
Q1
Sell
-6,500
Closed -$344K 1254
2022
Q4
$344K Sell
6,500
-3,000
-32% -$150K ﹤0.01% 927
2022
Q3
$442K Buy
+9,500
New +$496K 0.01% 838
2021
Q1
Sell
-6,800
Closed -$216K 1206
2020
Q4
$216K Buy
+6,800
New +$179K ﹤0.01% 1050

Other funds holding ITCI

Virginia Retirement Systems's ITCI Position: Q2 2025 in Review

Virginia Retirement Systems sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 6,928 shares — an estimated $914K sold.

Virginia Retirement Systems first reported a position in ITCI in Q4 2020 and held it in 5 quarters. The position peaked at $914K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • Virginia Retirement Systems reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • Virginia Retirement Systems sold 6,928 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $914K.
  • Virginia Retirement Systems first reported a position in Intra-Cellular Therapies Inc. in Q4 2020 and held it in 5 quarters.
  • Virginia Retirement Systems's Intra-Cellular Therapies Inc. position peaked at $914K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Virginia Retirement Systems's 13F filing for Q2 2025, filed 29 Jul 2025.